Published in Mov Disord on August 24, 2011
Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study. Brain (2014) 1.70
The spectrum of nonmotor symptoms in early Parkinson disease. Neurology (2013) 1.29
Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management. Front Neurol (2012) 0.98
Verbal memory is associated with structural hippocampal changes in newly diagnosed Parkinson's disease. J Neurol Neurosurg Psychiatry (2012) 0.93
Deep brain stimulation and cognitive decline in Parkinson's disease: a clinical review. Front Neurol (2012) 0.92
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson's disease. J Neurol (2014) 0.87
Impulse control disorders in Parkinson's disease: the role of personality and cognitive status. J Neurol (2012) 0.83
Impulsive and compulsive behaviors in Parkinson's disease. Front Aging Neurosci (2014) 0.82
Relationship between Motor Symptoms, Cognition, and Demographic Characteristics in Treated Mild/Moderate Parkinson's Disease. PLoS One (2015) 0.79
Mild cognitive impairment in Parkinson disease: heterogenous mechanisms. J Neural Transm (Vienna) (2012) 0.79
Validation of the Italian version of Parkinson's disease-cognitive rating scale (PD-CRS). Neurol Sci (2013) 0.78
Subclinical visuospatial impairment in Parkinson's disease: the role of Basal Ganglia and limbic system. Front Neurol (2014) 0.75
Verbal Memory in Parkinson's Disease: A Combined DTI and fMRI Study. J Parkinsons Dis (2015) 0.75
Assessment of cognitive impairment in patients with Parkinson's disease: prevalence and risk factors. Clin Interv Aging (2014) 0.75
Remission of cognitive deficits in Parkinson's disease: recovery from a nonamnestic mild cognitive impairment or psychiatric symptoms remission? Case Rep Psychiatry (2012) 0.75
Cognitive Training in Parkinson's Disease: A Review of Studies from 2000 to 2014. Parkinsons Dis (2016) 0.75
Drosophila PINK1 and parkin loss-of-function mutants display a range of non-motor Parkinson's disease phenotypes. Neurobiol Dis (2017) 0.75
Therapy-resistant symptoms in Parkinson's disease. J Neural Transm (Vienna) (2015) 0.75
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med (2006) 10.89
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord (2008) 9.52
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA (2009) 7.29
Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord (2007) 6.92
Alzheimer's disease. Lancet (2011) 5.35
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord (2012) 5.12
Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med (2004) 4.56
Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. BMJ (2011) 4.37
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord (2007) 3.86
Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement. JAMA Neurol (2013) 3.70
Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord (2007) 3.48
Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. Hum Mol Genet (2010) 3.34
Cognitive impairment and PD patients' capacity to consent to research. Neurology (2013) 3.22
Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord (2006) 2.96
A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord (2008) 2.81
Dementia with Lewy bodies. Lancet Neurol (2004) 2.66
Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord (2007) 2.62
Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. Br J Psychiatry (2003) 2.61
Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord (2006) 2.47
Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology (2007) 2.32
Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease. Mov Disord (2014) 2.30
Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations. Mov Disord (2008) 2.28
MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord (2011) 2.27
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol (2010) 2.26
A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease. Int J Geriatr Psychiatry (2004) 2.21
Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord (2010) 2.20
Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease. Ann Neurol (2010) 2.20
Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families. Eur J Hum Genet (2009) 2.16
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease. Mov Disord (2011) 2.05
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease. Mov Disord (2006) 2.04
Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov Disord (2012) 1.99
Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score. J Am Geriatr Soc (2008) 1.92
Life with communication changes in Parkinson's disease. Age Ageing (2006) 1.90
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial. Lancet (2012) 1.88
Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. Lancet Neurol (2012) 1.86
Impulse control disorders in Parkinson disease: a multicenter case--control study. Ann Neurol (2011) 1.73
Controlled study of decision-making and cognitive impairment in Parkinson's disease. Mov Disord (2007) 1.73
Scales to assess psychosis in Parkinson's disease: Critique and recommendations. Mov Disord (2008) 1.71
A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol (2010) 1.70
Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease. J Neurol Neurosurg Psychiatry (2012) 1.66
Sertraline for the treatment of depression in Alzheimer disease. Am J Geriatr Psychiatry (2010) 1.60
Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease. Mov Disord (2011) 1.57
Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. Mov Disord (2010) 1.56
Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov Disord (2007) 1.55
CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry (2010) 1.55
Parkinson disease with dementia: comparing patients with and without Alzheimer pathology. Alzheimer Dis Assoc Disord (2009) 1.54
Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study. J Neurol Neurosurg Psychiatry (2009) 1.54
Progression of motor impairment and disability in Parkinson disease: a population-based study. Neurology (2005) 1.53
Risk factors for Alzheimer disease: a population-based case-control study in Istanbul, Turkey. Alzheimer Dis Assoc Disord (2003) 1.52
Neuropsychological profile of patients with Parkinson's disease without dementia. Dement Geriatr Cogn Disord (2003) 1.51
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies. J Neurol Neurosurg Psychiatry (2010) 1.50
Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism Relat Disord (2008) 1.49
Validation of the Unified Parkinson's Disease Rating Scale (UPDRS) section I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease. Parkinsonism Relat Disord (2007) 1.48
Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study--the Bergen District Nursing Home Study (BEDNURS). Int J Geriatr Psychiatry (2008) 1.47
Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents. J Clin Psychiatry (2003) 1.45
Patterns of cortical thickness associated with impulse control disorders in Parkinson's disease. Mov Disord (2015) 1.45
Independent domains of gait in older adults and associated motor and nonmotor attributes: validation of a factor analysis approach. J Gerontol A Biol Sci Med Sci (2012) 1.45
Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease. Mov Disord (2008) 1.45
Aggressive course of disease in dementia. Alzheimers Dement (2006) 1.44
Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease. Mov Disord (2013) 1.41
APOE ε4 increases risk for dementia in pure synucleinopathies. JAMA Neurol (2013) 1.41
A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry (2006) 1.39
Impulsive and compulsive behaviors in Parkinson's disease. Mov Disord (2009) 1.38
Association between cognition and function in patients with Parkinson disease with and without dementia. Mov Disord (2010) 1.37
Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol (2004) 1.33
Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging. Int J Geriatr Psychiatry (2003) 1.32
Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF. Proc Natl Acad Sci U S A (2009) 1.32
Citalopram for agitation in Alzheimer's disease: design and methods. Alzheimers Dement (2012) 1.31
Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia. Mov Disord (2010) 1.31
Hypertension is a potential risk factor for vascular dementia: systematic review. Int J Geriatr Psychiatry (2010) 1.28
Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions. Neurosci Lett (2003) 1.27
Long-term follow-up of impulse control disorders in Parkinson's disease. Mov Disord (2008) 1.27
Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia. Dement Geriatr Cogn Disord (2003) 1.27
Cognitive impairment and dementia in Parkinson's disease. Neurobiol Dis (2012) 1.26
The effect of staff training on agitation and use of restraint in nursing home residents with dementia: a single-blind, randomized controlled trial. J Clin Psychiatry (2010) 1.25
Association between vitamin D receptor gene polymorphism and Alzheimer's disease. Tohoku J Exp Med (2007) 1.24
Anxiety rating scales in Parkinson's disease: critique and recommendations. Mov Disord (2008) 1.24
Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes. Arch Neurol (2011) 1.23
Decreased ventral striatal activity with impulse control disorders in Parkinson's disease. Mov Disord (2010) 1.22
Assessment and treatment of pain in people with dementia. Nat Rev Neurol (2012) 1.22
Verbal memory in drug-naive, newly diagnosed Parkinson's disease. The retrieval deficit hypothesis revisited. Neuropsychology (2011) 1.22
Optimised anaesthesia to reduce post operative cognitive decline (POCD) in older patients undergoing elective surgery, a randomised controlled trial. PLoS One (2012) 1.21
Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol (2008) 1.21
Who suffers most? Dementia and pain in nursing home patients: a cross-sectional study. J Am Med Dir Assoc (2008) 1.20
Cognitive predictors of dementia in Parkinson's disease: a community-based, 4-year longitudinal study. J Geriatr Psychiatry Neurol (2005) 1.19
Hard to swallow: dysphagia in Parkinson's disease. Age Ageing (2006) 1.19
Suicidal and death ideation in Parkinson's disease. Mov Disord (2008) 1.17